DekaBank Deutsche Girozentrale
MNTA

DekaBank Deutsche Girozentrale’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32,000
Closed -$439K – 1261
2019
Q3 		$439K Sell
32,000
-32,000
-50% -$386K ﹤0.01% 787
2019
Q2 		$791K Buy
64,000
+19,490
+44% +$259K ﹤0.01% 830
2019
Q1 		$1.17M Buy
44,510
+5,788
+15% +$73.9K 0.01% 728
2018
Q4 		$410K Sell
38,722
-5,788
-13% -$80.6K ﹤0.01% 858
2018
Q3 		$1.17M Buy
44,510
+2,750
+7% +$74.3K 0.01% 742
2018
Q2 		$831K Buy
41,760
+3,760
+10% +$80.7K 0.01% 790
2018
Q1 		$676K Sell
38,000
-800
-2% -$13.3K ﹤0.01% 811
2017
Q4 		$621K Hold
38,800
– – ﹤0.01% 783
2017
Q3 		$621K Hold
38,800
– – ﹤0.01% 790
2017
Q2 		$663K Hold
38,800
– – 0.01% 781
2017
Q1 		$512K Sell
38,800
-3,300
-8% -$51.7K ﹤0.01% 735
2016
Q4 		$629K Buy
42,100
+3,200
+8% +$42.3K 0.01% 624
2016
Q3 		$443K Hold
38,900
– – ﹤0.01% 689
2016
Q2 		$412K Buy
38,900
+9,100
+31% +$93.9K ﹤0.01% 712
2016
Q1 		$266K Sell
29,800
-5,200
-15% -$56K ﹤0.01% 786
2015
Q4 		$516K Buy
35,000
+700
+2% +$11.7K 0.01% 696
2015
Q3 		$563K Buy
34,300
+1,700
+5% +$34.8K 0.01% 670
2015
Q2 		$744K Buy
32,600
+6,800
+26% +$135K 0.01% 616
2015
Q1 		$392K Sell
25,800
-2,300
-8% -$29.9K ﹤0.01% 775
2014
Q4 		$335K Sell
28,100
-3,000
-10% -$34.3K ﹤0.01% 777
2014
Q3 		$353K Buy
31,100
+1,000
+3% +$11.4K ﹤0.01% 732
2014
Q2 		$364K Sell
30,100
-1,500
-5% -$17.7K 0.01% 669
2014
Q1 		$368K Buy
31,600
+1,800
+6% +$30.5K 0.01% 629
2013
Q4 		$536K Buy
29,800
+800
+3% +$13.4K 0.01% 534
2013
Q3 		$417K Buy
+29,000
New +$444K 0.01% 573

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MNTA Position: Q4 2019 in Review

DekaBank Deutsche Girozentrale sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2019, closing a stake of 32,000 shares — an estimated $439K sold.

DekaBank Deutsche Girozentrale first reported a position in MNTA in Q3 2013 and held it in 25 quarters. The position peaked at $1.17M in Q1 2019. 170 funds tracked by Wall St. Rank hold MNTA as of Q4 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 32,000 Momenta Pharmaceuticals, Inc. shares in Q4 2019, an estimated $439K.
  • DekaBank Deutsche Girozentrale first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 25 quarters.
  • DekaBank Deutsche Girozentrale's Momenta Pharmaceuticals, Inc. position peaked at $1.17M in Q1 2019.
  • 170 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.